Avacta Group Acquires Coris BioConcept for $9.2 Million
Avacta Group plc has acquired Coris BioConcept for £7.4 million, approximately $9.2 million USD, with an earnout based on future business performance, payable in cash, of up to £3 million. According to data captured in the LevinPro HC database, this marks the 63rd Laboratories, MRI and Dialysis transaction of the year and the 31st in the diagnostic subsector. Coris BioConcept is a middle-sized company specialized in developing, manufacturing and marketing rapid diagnostic test kits, mainly lateral flow tests, for use by healthcare professionals. Coris BioConcept was established in 1996 and is based in Gembloux, Belgium. Avacta Group plc is a life sciences company. The company is focused on... Read More »
healthŌme Acquires Kailos Genetics
healthŌme™ Inc. announced earlier this week its acquisition of Kailos Genetics, LLC for an undisclosed price. Kailos Genetics is a CLIA-certified and CAP-accredited genetic testing laboratory and supplier of clinical grade laboratory reagents for next-generation sequencing. healthŌme is a leading genomics-based, health navigation company based at the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama. healthŌme, in partnership with Hannover Re US, the reinsurer for healthŌme’s new first-of-its-kind, patent pending cancer program, designs, develops and delivers its health management solutions through a network of life and critical insurance carriers. With the acquisition, Kailos... Read More »
MedGenome Acquires Prognosis Laboratories
MedGenome Labs Ltd. announced on May 29 that it acquired Prognosis Laboratories for an undisclosed price. Wodehouse Capital was the exclusive financial advisor to Prognosis Laboratories. Wodehouse Capital was assisted by Khaitan & Co. as legal advisors to the undisclosed sellers. Prognosis Laboratories is a private diagnostic center in India that has been granted permission to conduct COVID-19 tests. It also provides cardiology, radio diagnosis, pathology, infertility, ultrasonography, ECG, hematology and digital X-ray services. It was founded in 2013 and is based in Dwarka, New Delhi. MedGenome Labs is a leading genetic diagnostics and research and data company based in India,... Read More »
MedVenture Health Acquires Canyon Labs
On May 16, MedVenture Health, a venture capital and private equity firm, announced it acquired Canyon Labs for an undisclosed price. According to the LevinPro HC database, this acquisition represents the 55th Laboratories, MRI and Dialysis transaction of the year. Canyon Labs provides laboratory testing, consulting, clinical research and Institutional Review Board services for pharmaceutical, nutraceutical and medical devices. It is based in Bluffdale, Utah. MedVenture partners with entrepreneurs, physicians and management teams to advance healthcare products, services and technologies. It is based in Salt Lake City, Utah and was founded in 2016. This marks MedVenture’s first... Read More »
Mixed Q1 2023 Results in the Diagnostics Sector: COVID-19 Testing Revenues Slump
The Diagnostics Market: Despite a bustling M&A market in 2022, the diagnostics sector appears to have experienced a slowdown in deal activity, though it still remains relatively strong compared with previous years. As of May 15, 2023, a total of 26 deals have been announced year-to-date. Although this represents a 42% decline compared to the 45 deals observed during the same period in 2022, it still signifies a substantial 44% and 86% increase from the deal count in 2021 and 2020, respectively. These figures highlight the enduring interest in the diagnostics market, which increased out of necessity during the COVID-19 pandemic and continues to drive investment and strategic... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
